tradingkey.logo

Danaher Corp

DHR
View Detailed Chart

199.640USD

-0.750-0.37%
Market hours ETQuotes delayed by 15 min
143.56BMarket Cap
36.82P/E TTM

Danaher Corp

199.640

-0.750-0.37%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.37%

5 Days

-5.11%

1 Month

-3.90%

6 Months

-27.11%

Year to Date

-13.02%

1 Year

-18.82%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 28 analysts
BUY
Current Rating
263.066
Target Price
28.22%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

91
Total
4
Median
7
Average
Company name
Ratings
Analysts
Danaher Corp
DHR
28
Intuitive Surgical Inc
ISRG
33
Boston Scientific Corp
BSX
33
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
32
1
2
3
...
18

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(10)
Neutral(2)
Buy(0)
Indicators
Sell(4)
Neutral(2)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-1.178
Sell
RSI(14)
36.335
Neutral
STOCH(KDJ)(9,3,3)
16.915
Sell
ATR(14)
4.677
High Vlolatility
CCI(14)
-135.652
Sell
Williams %R
94.072
Oversold
TRIX(12,20)
-0.094
Sell
StochRSI(14)
33.636
Neutral
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
203.198
Sell
MA10
207.313
Sell
MA20
208.049
Sell
MA50
214.729
Sell
MA100
225.469
Sell
MA200
244.248
Sell

News

More news coming soon, stay tuned...

Company

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Company codeDHR
CompanyDanaher Corp
CEOMr. Rainer M. Blair
Websitehttps://www.danaher.com/
tradingkey.logo
tradingkey.logo
Intraday Data provided by Refinitiv and subject to terms of use. Historical and current end-of-day data provided by Refinitiv. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.